04:55 PM EDT, 07/12/2024 (MT Newswires) -- Eliem Therapeutics ( ELYM ) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to 36.8 million shares by some selling stockholders from time to time.

The company said it won't get any proceeds from the sale of the shares.

The shares were issued to the stockholders in connection with Eliem's acquisition of Tenet Medicines and the company's simultaneous private placement in June, the company said.

Eliem shares rose 2.1% in Friday trading.

Price: 7.22, Change: +0.15, Percent Change: +2.12